Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Atossa Therapeutics Inc
(NQ:
ATOS
)
1.450
+0.030 (+2.11%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Atossa Therapeutics Inc
< Previous
1
2
3
4
5
Next >
ATOS Stock Earnings: Atossa Therapeutics Beats EPS for Q2 2024
August 12, 2024
ATOS stock results show that Atossa Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
3 Dirt-Cheap Drug Developers With Blockbuster Potential
July 11, 2024
These are three of the best cheap drug developer stocks for investors to keep an eye as their growth could be imminent.
Via
InvestorPlace
3 Penny Stock Moonshots with 300%+ Upside Potential by 2025
July 03, 2024
If you understand the risks of penny stocks with upside, you may want to investigate these three stocks today.
Via
InvestorPlace
Meme Mania Meets Medicine: 3 Biotech Stocks Primed to Soar
June 07, 2024
These are the biotech stocks to buy for a meme rally as they represent companies with positive impending news related to clinical trials.
Via
InvestorPlace
3 Must-Buy Biotech Stocks Before the Summer Rally Kicks Off
May 20, 2024
With the innovation space possibly getting overstretched, these biotech stocks to buy could benefit from a sector rotation.
Via
InvestorPlace
MicroMarvel - Atossa Therapeutics
April 06, 2024
Atossa Therapeutics, a biopharmaceutical company focused on developing medicines in oncology, has a lead program in Phase II clinical trials for breast cancer, and 100% technical buy signals
Via
Talk Markets
Atossa Therapeutics backing Endoxifen in the fight against breast cancer
August 23, 2023
--News Direct--
Via
News Direct
Wall Street Favorites: 3 Biotech Stocks with Strong Buy Ratings for May 2024
May 17, 2024
With new innovation, millions of retiring baby boomers, and an increase in mergers, biotech stocks to buy have a good deal of upside ahead.
Via
InvestorPlace
ATOS Stock Earnings: Atossa Therapeutics Beats EPS for Q1 2024
May 13, 2024
ATOS stock results show that Atossa Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Shhh! 3 Secret Penny Stocks Flying Below Wall Street’s Radar
May 09, 2024
Under-the-radar penny stocks can be some of the most rewarding investments on the market. Here are three to consider.
Via
InvestorPlace
ATOS Stock Earnings: Atossa Therapeutics Misses EPS for Q4 2023
April 01, 2024
ATOS stock results show that Atossa Therapeutics missed analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Catalyst Countdown: 3 Biotech Stocks With Upcoming News That Could Move the Market
January 16, 2024
In the volatile world of biotech stocks, keeping an eye on the news is critical. Here are three companies to look out for.
Via
InvestorPlace
This Drug Developer Is Dedicated To "Transforming The Breast Cancer Paradigm"
October 24, 2023
Dr. Steven Quay MD, PhD, President & CEO of Atossa Therapeutics Inc. (NASDAQ: ATOS) was recently interviewed by Benzinga.
Via
Benzinga
Approximately 30% Of Newly Diagnosed Cancers In Women Will Be Breast Cancers - Atossa Therapeutics Has A Promising Drug To Help With Prevention And Treatment
September 18, 2023
Via
ACCESSWIRE
Approximately 30% Of Newly Diagnosed Cancers In Women Will Be Breast Cancers – Atossa Therapeutics Has A Promising Drug To Help With Prevention And Treatment
September 15, 2023
One in eight women will be diagnosed with breast cancer during
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
September 08, 2023
Via
Benzinga
Breast Cancer-Focused Atossa Therapeutics Can Possibly Change Treatment Paradigm: Analyst
September 08, 2023
Cantor Fitzgerald has initiated coverage of Atossa Therapeutics Inc (NASDAQ: ATOS) with an Overweight rating and
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
September 08, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 8, 2023
September 08, 2023
Via
Benzinga
Could Anixa Biosciences (NASDAQ: ANIX) Be Developing The Vaccine To End One Of The Deadliest Types Of Breast Cancer?
August 09, 2023
Cancer is a disease that affects millions of people around the world. Historically, cancer vaccines have not been very successful in treating or preventing the disease. However, recent research on the...
Via
Benzinga
50% Of Women Have Elevated Breast Density, Which Significantly Decreases the Effectiveness of Mammography - Atossa Therapeutics Is Looking To Ensure Earlier, Accurate Diagnosis
July 12, 2023
Via
ACCESSWIRE
50% Of Women Have Elevated Breast Density, Which Significantly Decreases The Effectiveness Of Mammography – Atossa Therapeutics Is Looking To Ensure Earlier, Accurate Diagnosis
July 11, 2023
One in eight women will be diagnosed with breast cancer during
Via
Benzinga
3 Penny Stocks to Make Your ‘Get Rich’ Dreams Come True
July 06, 2023
When it comes to potentially profitable penny stocks, some can create unimaginable fortunes for patient investors. Others, not so much.
Via
InvestorPlace
3 Penny Stocks Set to Pass the $5 Mark Soon
June 23, 2023
Here are three high potential penny stocks with recent news that could move them above the $5 mark in the next six to 12 months
Via
InvestorPlace
3 Penny Stocks That Could Skyrocket in the Next 12 Months
June 07, 2023
Find the top penny stocks to buy, and you can make a fortune. Pick the wrong one and there are also plenty of horrors.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
May 24, 2023
It's time for a dive into the biggest pre-market stock movers as we check out all of the latest news for Wednesday morning!
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
May 17, 2023
We're starting off Wednesday with a look at the biggest pre-market stock movers traders will want to keep an eye on this morning!
Via
InvestorPlace
7 High-Potential Penny Stocks in the Biotech Sector
May 04, 2023
Most of the biggest biotech stocks on the market started off as unknown penny stocks. Here are seven hot ones to consider.
Via
InvestorPlace
3 Best Penny Stocks Under $1 to Buy in April
April 11, 2023
By their very nature, the best penny stocks under $1 are a huge gamble with potentially huge returns for speculative investors.
Via
InvestorPlace
The 3 Best Biotech Stocks Under $1 to Buy for April
April 04, 2023
While risky, here are some of the best biotech stocks under $1, with solid catalysts, investors may want to consider.
Via
InvestorPlace
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.